GlassScriptPhysician profile
James A Oujiri
NPI 1134187412
$17,287.84
in general payments reported to CMS, 2019-2025
14 companies · $641 in 2025
The $641 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $283 · 2021: $314 · 2022: $5,728 · 2023: $3,800 · 2024: $6,522 · 2025: $641.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,287 · Food and Beverage: $2,676 · Consulting Fee: $2,000 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,287.03 |
| Food and Beverage | $2,676.21 |
| Consulting Fee | $2,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $7,946.17 | 2019-2024 | |
| Boston Scientific Corporation | $6,238.03 | 2019-2025 | Watchman Access System, Watchman Flx, Farapulse |
| Medtronic, INC. | $2,557.11 | 2023-2024 | Micra, Arctic Front Advance, Linq II |
| Abbott Laboratories | $159.08 | 2025 | Aveir |
| Novo Nordisk INC | $85.76 | 2024 | Wegovy, Ozempic |
| Cardiva Medical, INC. | $77.15 | 2022-2024 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Heartflow, INC. | $58.14 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $40.88 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $38.81 | 2024-2025 | Camzyos |
| Pfizer INC. | $20.34 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.17 | 2025 | |
| Medtronic Vascular, INC. | $16.24 | 2019 | |
| Teleflex LLC | $15.70 | 2025 | Manta |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Oujiri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.